Revolution Medicines (RVMD) Change in Acquisitions & Divestments (2019 - 2026)

Revolution Medicines has reported Change in Acquisitions & Divestments for 8 years, with the latest figure at $382.0 million in Q2 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 32.35% year-over-year to $382.0 million in Q2 2026; TTM through Jun 2026 was $1.6 billion, a 5.03% decrease from a year earlier, with the FY2025 full-year figure at $1.9 billion, up 20.72% from the prior year.
• Change in Acquisitions & Divestments was $382.0 million for Q2 2026 at Revolution Medicines, roughly flat from $383.9 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $564.6 million in Q2 2025, with the low at $93.1 million in Q3 2022.
• Average Change in Acquisitions & Divestments over 5 years is $311.4 million, with a median of $325.2 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2026: Change in Acquisitions & Divestments jumped 262.76% in 2024, then plunged 32.35% in 2026.
• Over 5 years, Change in Acquisitions & Divestments stood at $156.1 million in 2022, then decreased by 9.34% to $141.5 million in 2023, then jumped by 114.48% to $303.5 million in 2024, then gained by 22.98% to $373.3 million in 2025, then gained by 2.33% to $382.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $382.0 million (Q2 2026), $383.9 million (Q1 2026), and $373.3 million (Q4 2025), per Business Quant data.